Live feed06:30:00·1033dPRReleasevia QuantisnowRoyalty Pharma and Ferring Pharmaceuticals Enter Into US $500 Million Royalty Agreement for New Intravesical Gene Therapy Adstiladrin® (Nadofaragene Firadenovec-Vncg)ByQuantisnow·Wall Street's wire, on your screen.RPRX· Royalty Pharma plcHealth Care
